Contribution of gut microbiota to colonic and extracolonic cancer development

Digestive Diseases

Volumn 29, Issue 6, 2011, Pages 554-561

  Compare, Debora ^a   Nardone, Gerardo ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Adaptive immunity; Colorectal cancer; Gut microbiota; Innate immunity; Probiotics

Indexed keywords

ANTIBIOTIC AGENT; CARCINOGEN; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12; LIPOPOLYSACCHARIDE; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PATTERN RECOGNITION RECEPTOR; PROBIOTIC AGENT; STAT1 PROTEIN; STAT3 PROTEIN; STAT4 PROTEIN; STAT6 PROTEIN; SUPPRESSOR FACTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TRANSFORMING GROWTH FACTOR BETA;

ADAPTIVE IMMUNITY; ARTICLE; BACTEREMIA; BACTEROIDES FRAGILIS; BIFIDOBACTERIUM; BREAST CANCER; CANCER INCIDENCE; CANCER PATIENT; CANCER PREVENTION; CANCER RISK; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CELLULAR IMMUNITY; CHRONIC INFLAMMATION; CLINICAL TRIAL (TOPIC); COLON CARCINOGENESIS; COLORECTAL CANCER; CYTOKINE PRODUCTION; ENDOMETRIUM CANCER; EPITHELIUM CELL; ESCHERICHIA COLI; GALLBLADDER CANCER; HELICOBACTER INFECTION; HOMEOSTASIS; HUMAN; IMMUNE DEFICIENCY; IMMUNE EVASION; IMMUNE RESPONSE; INNATE IMMUNITY; INTESTINE FLORA; LIVER CARCINOGENESIS; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NONHUMAN; OVARY CANCER; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SMALL INTESTINE CARCINOMA; STOMACH CANCER; SYSTEMATIC REVIEW (TOPIC); TH1 CELL; TH17 CELL; TH2 CELL; TUMOR ABLATION; TUMOR GROWTH; TUMOR IMMUNITY;

COLON; COLONIC NEOPLASMS; HOST-PATHOGEN INTERACTIONS; HUMANS; METAGENOME; PRECANCEROUS CONDITIONS; PROBIOTICS;

EID: 84055190978     PISSN: 02572753     EISSN: 14219875     Source Type: Journal    
DOI: 10.1159/000332967     Document Type: Article

References (42)

1. de Martel C, Franceschi S: Infections and cancer: Established associations and new hypotheses. Crit Rev Oncol Hematol 2009; 70: 183-194.
2. Tlaskalová-Hogenová H, Stepánková R, Kozáková H, Hudcovic T, Vannucci L, Tucková L, Rossmann P, Hrncír T, Kverka M, Zákostelská Z, Klimešová K, Pribylová J, Bártová J, Sanchez D, Fundová P, Borovská D, Srutková D, Zídek Z, Schwarzer M, Drastich P, Funda DP: The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: Contribution of germ-free and gnotobiotic animal models of human diseases. Cell Mol Immunol 2011; 8: 110-120.
3. Round JL, Mazmanian SK: The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 2009; 9: 313-323.
4. Terzic J, Grivennikov S, Karin E, Karin M: Inflammation and colon cancer. Gastroenterology 2010; 138: 2101-2114.
5. Neish AS: Microbes in gastrointestinal health and disease. Gastroenterology 2009; 136: 65-80.
6. Ioannou S, Voulgarelis M: Toll-like receptors, tissue injury, and tumourigenesis. Mediators Inflamm 2010;pii:581837.
7. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R: Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell 2004; 118: 229-241. (Pubitemid 38962578)
8. Pull SL, Doherty JM, Mills JC, Gordon JI, Stappenbeck TS: Activated macrophages are an adaptive element of the colonic epithelial progenitor niche necessary for regenerative responses to injury. Proc Natl Acad Sci USA 2005; 102: 99-104. (Pubitemid 40094435)
9. Fukata M, Chen A, Klepper A, Krishnareddy S, Vamadevan AS, Thomas LS, Xu R, Inoue H, Arditi M, Dannenberg AJ, Abreu MT: Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: Role in proliferation and apoptosis in the intestine. Gastroenterology 2006; 131: 862-877. (Pubitemid 44316821)
10. Boraska Jelavic T, Barisic M, Drmic Hofman I, Boraska V, Vrdoljak E, Peruzovic M, Hozo I, Puljiz Z, Terzic J: Microsatelite GT polymorphism in the Toll-like receptor 2 is associated with colorectal cancer. Clin Genet 2006; 70: 156-160. (Pubitemid 44028102)
11. Zhang G, Ghosh S: Toll-like receptor-mediated NF-kappaB activation: A phylogenetically conserved paradigm in innate immunity. J Clin Invest 2001; 107: 13-19. (Pubitemid 32047406)
12. Izcue A, Coombes JL, Powrie F: Regulatory lymphocytes and intestinal inflammation. Annu Rev Immunol 2009; 27: 313-338.
13. Weaver CT, Hatton RD, Mangan PR, Harrington LE: IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 2007; 25: 821-852. (Pubitemid 46697925)
14. Dunn GP, Koebel CM, Schreiber RD: Interferons, immunity and cancer immunoediting. Nat Rev Immunol 2006; 6: 836-848. (Pubitemid 44631652)
15. Buonocore S, Ahern PP, Uhlig HH, Ivanov II, Littman DR, Maloy KJ, Powrie F: Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 2010; 464: 1371-1375.
16. Ji Y, Zhang W: Th17 cells: Positive or negative role in tumor? Cancer Immunol Immunother 2010; 59: 979-987.
17. Yang ZZ, Ansell SM: The role of Treg cells in the cancer immunological response. Am J Immunol 2009; 5: 17-28.
18. Greer JB, O'Keefe SJ: Microbial induction of immunity, inflammation, and cancer. Front Physiol 2011; 1: 168.
19. Reddy BS, Mastromarino A, Wynder EL: Further leads on metabolic epidemiology of large bowel cancer. Cancer Res 1975;35: 3403-3406.
20. Vannucci L, Stepankova R, Kozakova H, Fiserova A, Rossmann P, Tlaskalova-Hogenova H: Colorectal carcinogenesis in germ-free and conventionally reared rats: Different intestinal environments affect the systemic immunity. Int J Oncol 2008; 32: 609-617. (Pubitemid 351330467)
21. Rakoff-Nahoum S, Medzhitov R: Role of Toll-like receptors in tissue repair and tumorigenesis. Biochemistry (Mosc) 2008; 73: 555-561. (Pubitemid 351775078)
22. Gold JS, Bayar S, Salem RR: Association of Streptococcus bovis bacteremia with colonic neoplasia and extracolonic malignancy. Arch Surg 2004; 139: 760-765. (Pubitemid 38886513)
23. Ellmerich S, Scholler M, Duranton B, et al: Promotion of intestinal carcinogenesis by Streptococcus bovis. Carcinogenesis 2000; 21: 753-756. (Pubitemid 30214033)
24. Sears CL, Islam S, Saha A, Arjumand M, Alam NH, Faruque AS, Salam MA, Shin J, Hecht D, Weintraub A, Sack RB, Qadri F: Association of enterotoxigenic Bacteroides fragilis infection with inflammatory diarrhea. Clin Infect Dis 2008; 47: 797-803.
25. Toprak NU, Yagci A, Gulluoglu BM, Akin ML, Demirkalem P, Celenk T, Soyletir G: A possible role of Bacteroides fragilis enterotoxin in the aetiology of colorectal cancer. Clin Microbiol Infect 2006; 12: 782-786. (Pubitemid 43983804)
26. Wu S, Morin PJ, Mauyo DJIK, Sears C: Bacteroides fragilis enterotoxin induces c-myc expression and cellular proliferation. Gastroenterology 2003; 124: 392-400. (Pubitemid 36169256)
27. Wu S, Rhee KJ, Albesiano E, Rabizadeh S, Wu X, Yen HR, Huso DL, Brancati FL, Wick E, McAllister F, Housseau F, Pardoll DM, Sears CL: A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med 2009; 15: 1016-1022.
28. Cuevas-Ramos G, Petit CR, Marcq I, Boury M, Oswald E, Nougayréde JP: Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. Proc Natl Acad Sci USA 2010; 107: 11537-11542.
29. Gueimonde M, Ouwehand A, Huhtinen H, Salminen E, Salminen S: Qualitative and quantitative analyses of the bifidobacterial microbiota in the colonic mucosa of patients with colorectal cancer, diverticulitis and inflammatory bowel disease. World J Gastroenterol 2007; 13: 3985-3989. (Pubitemid 47272497)
30. Shen XJ, Rawls JF, Randall T, Burcal L, Mpande CN, Jenkins N, Jovov B, Abdo Z, Sandler RS, Keku TO: Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas. Gut Microbes 2010; 1: 138-147.
31. Sobhani I, Tap J, Roudot-Thoraval F, Roperch JP, Letulle S, Langella P, Corthier G, Tran Van Nhieu J, Furet JP: Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS One 2011; 6:e16393.
32. Yu LX, Yan HX, Liu Q, Yang W, Wu HP, Dong W, Tang L, Lin Y, He YQ, Zou SS, Wang C, Zhang HL, Cao GW, Wu MC, Wang HY: Endotoxin accumulation prevents carcinogen- induced apoptosis and promotes liver tumorigenesis in rodents. Hepatology 2010; 52: 1322-1333.
33. Rao VP, Poutahidis T, Ge Z, et al: Innate immune inflammatory response against enteric bacteria Helicobacter hepaticus induces mammary adenocarcinoma in mice. Cancer Res 2006; 66: 7395-7400. (Pubitemid 44289190)
34. Rao VP, Poutahidis T, Ge Z, et al: Proinflammatory CD4+ CD45RBhi lymphocytes promote mammary and intestinal carcinogenesis in ApcMin/+ mice. Cancer Res 2006; 66: 57-61. (Pubitemid 43166009)
35. Rao VP, Poutahidis T, Fox JG, Erdman SE: Breast cancer: Should gastrointestinal bacteria be on our radar screen? Cancer Res 2007; 67: 847-850.
36. Liong MT: Roles of probiotics and prebiotics in colon cancer prevention: Postulated mechanisms and in-vivo evidence. Int J Mol Sci 2008; 9: 854-863.
37. Malhotra SL: Dietary factors in a study of colon cancer from cancer registry, with special reference to the role of saliva, milk and fermented milk products and vegetable fibre. Med Hypotheses 1977; 3:122-134.
38. Peters RK, Pike MC, Garabrant D, Mack TM: Diet and colon cancer in Los Angeles County, California. Cancer Causes Control 1992; 3: 457-473.
39. Young TB, Wolf DA: Case-control study of proximal and distal colon cancer and diet in Wisconsin. Int J Cancer 1988; 42: 167-175.
40. Kampman E, Giovannucci E, van't Veer P, Rimm E, Stampfer MJ, Colditz GA, Kok FJ, Willett WC: Calcium, vitamin D, dairy foods and the occurrence of colorectal adenomas among men and women in two prospective studies. Am J Epidemiol 1994; 139: 16-29. (Pubitemid 24048062)
41. Kampman E, Goldbohm RA, van den Brandt PA, van't Veer P: Fermented dairy products, calcium and colorectal cancer in the Netherlands cohort study. Cancer Res 1994; 54: 3186-3190. (Pubitemid 24208926)
42. Capurso G, Marignani M, Delle Fave G: Probiotics and the incidence of colorectal cancer: When evidence is not evident. Dig Liver Dis 2006; 38(suppl 2):S277-S282. (Pubitemid 46140769)